Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris

Sohag University

Status: Not yet enrolling

Conditions: Acne Vulgaris

Treatments: Diagnostic Test: serum asprosin

Study type: Interventional

Funder types: Other

Identifiers

NCT05471388

Soh-Med-22-07-06

Details and patient eligibility

About

Subject of interest is to evaluate serum level of asprosin in male patients with acne vulgaris, demonstrate the relation between acne vulgaris severity and level of asprosin in these patients & the relation between metabolic syndrome in acne vulgaris and level of asprosin.

Enrollment: 72 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Acne vulgaris male patients (>18 years) will be included.

Exclusion criteria

• Age <18 years.
• Females.
• Patients with other inflammatory skin disorders.
• Patients with associated systemic diseases.
• Current or previous treatment with isotretinoin in the last 3 month ,anti-inflammatory drugs, systemic antibiotics, androgen or anti androgen therapy, and steroid therapy).
• Patients known on treatment of diabetes, hypertension and dyslipidemia.
• Athletes.
• Patient refusal.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

72 participants in 2 patient groups

case

Active Comparator group

Treatment:

Diagnostic Test: serum asprosin

control

Active Comparator group

Treatment:

Diagnostic Test: serum asprosin